What happened Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) said BDR Pharmaceuticals International Pvt. Ltd. filed suit against the FDA and related Federal Defendants on October 23, 2026. The case was filed in the United States District Court for the District of Columbia. It challenges FDA's refusal to receive an abbreviated new drug application referencing Phathom's NDA […]